Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 1
1996 8
1997 5
1998 4
1999 3
2000 4
2001 8
2002 7
2003 5
2004 7
2005 10
2006 5
2007 8
2008 7
2009 6
2010 7
2011 4
2012 4
2013 2
2014 5
2015 3
2016 4
2017 5
2018 5
2019 6
2020 14
2021 34
2022 10
Text availability
Article attribute
Article type
Publication date

Search Results

183 results
Results by year
Filters applied: . Clear all
Page 1
Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19.
Razonable RR, Pawlowski C, O'Horo JC, Arndt LL, Arndt R, Bierle DM, Borgen MD, Hanson SN, Hedin MC, Lenehan P, Puranik A, Seville MT, Speicher LL, Tulledge-Scheitel SM, Venkatakrishnan AJ, Wilker CG, Badley AD, Ganesh R. Razonable RR, et al. Among authors: badley ad. EClinicalMedicine. 2021 Oct;40:101102. doi: 10.1016/j.eclinm.2021.101102. Epub 2021 Aug 30. EClinicalMedicine. 2021. PMID: 34485873 Free PMC article.
LENZILUMAB EFFICACY AND SAFETY IN NEWLY HOSPITALIZED COVID-19 SUBJECTS: RESULTS FROM THE LIVE-AIR PHASE 3 RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL.
Temesgen Z, Burger CD, Baker J, Polk C, Libertin C, Kelley C, Marconi VC, Orenstein R, Durrant C, Chappell D, Ahmed O, Chappell G, Badley AD. Temesgen Z, et al. Among authors: badley ad. medRxiv. 2021 May 5:2021.05.01.21256470. doi: 10.1101/2021.05.01.21256470. Preprint. medRxiv. 2021. PMID: 33972949 Free PMC article.
Research Response to SARS-CoV-2/COVID-19.
Burger CD, Mikhail AE, Orenstein R, Ebbert JO, Vergidis P, Badley AD. Burger CD, et al. Among authors: badley ad. Mayo Clin Proc. 2020 Sep;95(9S):S52-S55. doi: 10.1016/j.mayocp.2020.06.048. Epub 2020 Jul 7. Mayo Clin Proc. 2020. PMID: 32807524 Free PMC article. Review. No abstract available.
Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial.
Temesgen Z, Burger CD, Baker J, Polk C, Libertin CR, Kelley CF, Marconi VC, Orenstein R, Catterson VM, Aronstein WS, Durrant C, Chappell D, Ahmed O, Chappell G, Badley AD; LIVE-AIR Study Group. Temesgen Z, et al. Among authors: badley ad. Lancet Respir Med. 2022 Mar;10(3):237-246. doi: 10.1016/S2213-2600(21)00494-X. Epub 2021 Dec 1. Lancet Respir Med. 2022. PMID: 34863332 Free PMC article. Clinical Trial.
Calm before the Storm.
Braga Neto MB, Badley AD, Parikh SA, Graham RP, Kamath PS. Braga Neto MB, et al. Among authors: badley ad. N Engl J Med. 2022 Feb 3;386(5):479-485. doi: 10.1056/NEJMcps2111163. N Engl J Med. 2022. PMID: 35108473 Free PMC article. No abstract available.
COVID-19 Ethics and Research.
Meagher KM, Cummins NW, Bharucha AE, Badley AD, Chlan LL, Wright RS. Meagher KM, et al. Among authors: badley ad. Mayo Clin Proc. 2020 Jun;95(6):1119-1123. doi: 10.1016/j.mayocp.2020.04.019. Epub 2020 Apr 24. Mayo Clin Proc. 2020. PMID: 32402511 Free PMC article. No abstract available.
The long road to TRAIL therapy: a TRAILshort detour.
Chandrasekar AP, Maynes M, Badley AD. Chandrasekar AP, et al. Among authors: badley ad. Oncotarget. 2021 Mar 30;12(7):589-591. doi: 10.18632/oncotarget.27902. eCollection 2021 Mar 30. Oncotarget. 2021. PMID: 33868580 Free PMC article. No abstract available.
Casp8p41 and HIV.
Cummins NW, Badley AD. Cummins NW, et al. Among authors: badley ad. Oncotarget. 2015 Sep 15;6(27):23042-3. doi: 10.18632/oncotarget.5238. Oncotarget. 2015. PMID: 26309081 Free PMC article. No abstract available.
183 results